S. Consolo et al., The parafascicular thalamic nucleus but not the prefrontal cortex facilitates the nitric oxide cyclic GMP pathway in rat striatum, NEUROSCIENC, 91(1), 1999, pp. 51-58
We investigated whether the parafascicular thalamic nucleus and the prefron
tal cortex, the two major excitatory inputs to the striatum, modulate the n
itric oxide/cyclic GMP pathway in rat striatum. Electrical stimulation (10
pulses of 0.5 ms, 10 V applied at 10 Hz, 140 mu A) delivered bilaterally to
the parafascicular thalamic nucleus for a total of 4, 10 and 20 min, time-
dependently facilitated cyclic GMP output in the dorsal striatum of freely
moving rats, assessed by trans-striatal microdialysis. Electrical stimulati
on to the prefrontal cortex for a total duration of 20 min did not affect s
triatal cyclic GMP levels. The facilitatory effect observed after electrica
l stimulation of the parafascicular thalamic nucleus was blocked by co-perf
usion with tetrodotoxin, suggesting that the effect is mediated by neuronal
process(es). The non-competitive N-methyl-D-aspartate receptor antagonist,
dizocilpine maleate (30 mu M infused into the dorsal striatum), and the co
mpetitive one, 3-[(R)-carboxypiperazin-4-yl]-propyl-phosphonic acid (50 mu
M infused), but not local perfusion of the alpha-amino-3-hydroxy-5-methyl-i
soxazole-4-acid antagonist, 6-nitro-7-sulphamoylbenzo(f)quinoxaline-2,3-dio
ne (15 mu M perfused locally), abolished the cyclic GMP response in the str
iatum. The nitric oxide synthase inhibitor, 7-nitroindazole, applied locall
y (1 mM), blocked the electrically evoked increase in striatal extracellula
r cyclic GMP. This increase was also prevented by local application (100 an
d 300 mu M) of 1H-(1,2,4)-oxadiazolo-(4,3a)-quinoxalin-1-one, a selective i
nhibitor of soluble guanylyl cyclase.
The results provide direct functional evidence of selective thalamic facili
tation of the nitric oxide/cyclic GMP pathway in the dorsal striatum, throu
gh activation of N-methyl-D-aspartate receptors. (C) 1999 IBRO. Published b
y Elsevier Science Ltd.